StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of Ayala Pharmaceuticals stock opened at $0.54 on Wednesday. The company’s 50-day moving average price is $0.70 and its two-hundred day moving average price is $0.74. Ayala Pharmaceuticals has a 52 week low of $0.50 and a 52 week high of $1.95. The stock has a market cap of $5.81 million, a PE ratio of -0.07 and a beta of 1.62.
Ayala Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Ayala Pharmaceuticals
- What is the Australian Securities Exchange (ASX)
- High-Yield Texas Instruments Could Hit New Highs Soon
- Business Services Stocks Investing
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.